IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and speciality chemicals, announced receiving EDQM certification to supply Pantoprazole Sodium Sesquihydrate API across the European market.

Pantoprazole Sodium Sesquihydrate is a proton pump inhibitor used in drugs to suppress gastric acid secretion.

The company started production of Pantoprazole Sodium Sesquihydrate in Q3 FY 2020 at its Punjab-based facility. With this CEP certification, the Company will now be able to export it to entire Europe. IOL currently, has a total capacity of producing 240 TPA of antoprazole Sodium Sesquihydrate.

IOL is the world's largest producer of Ibuprofen API with 33 per cent market share globally. The company has 13 plus APIs in its portfolio such as Metformin Hydrochloride, Clopidogrel Bisulfate Form II, Fenofibrate, Paracetamol etc.